| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.00023 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.00022 | 1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -4.1e-05 | 1 |